웰바이오텍웰바이오텍
010600 · KOSPI · ₩010600 · 웰바이오텍
₩11▼ ₩4 (26.67%)End-of-day · Jan 23, 2026 · End-of-day prices.
Filings
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 11, 2026Open on DART
- Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)May 20, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)Apr 30, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 31, 2026Open on DART
- Capital reduction decision주요사항보고서(감자결정)Mar 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 27, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jan 27, 2026Open on DART
- Delisting기타시장안내 (상장폐지결정 효력정지 가처분 신청 기각결정에 따른 정리매매절차 재개)Jan 9, 2026Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Other Market Notice (Notice That Substantive Review of Listing Eligibility Not Yet Proceeding Due to Violation of Accounting Standards)기타시장안내 (회계처리기준 위반행위 관련 상장적격성 실질심사 절차 미진행 안내)Oct 29, 2025Open on DART
- Measures Such as Criminal Referral Due to Violation of Accounting Standards회계처리기준위반에따른검찰고발등조치Oct 29, 2025Open on DART
- Occurrence of Adverse Opinion, Disclaimer of Opinion, or Complete Capital Impairment in Semi-Annual Review Report반기검토의견부적정,의견거절또는완전자본잠식사실발생Aug 14, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Confirmation of Embezzlement/Breach of Trust횡령ㆍ배임사실확인Jun 5, 2025Open on DART
- Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)May 27, 2025Open on DART
- Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)May 27, 2025Open on DART
- Other management matters기타경영사항(자율공시) (상장폐지결정 효력정지 가처분 신청)May 20, 2025Open on DART
- Other Market Notice (Results of Listing and Disclosure Committee)기타시장안내 (상장·공시위원회 결과)May 19, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Other Market Notice (Receipt of Request for Deliberation on Whether Improvement Plan Has Been Implemented)기타시장안내 (개선계획 이행여부 심의요청서 접수)Apr 23, 2025Open on DART
- Other Market Notice (Improvement Period Ended)기타시장안내 (개선기간 종료)Apr 14, 2025Open on DART
- Delisting기타시장안내 (상장폐지 이의신청서 제출)Apr 10, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 28, 2025Open on DART
- Delisting기타시장안내 (상장폐지 관련 안내)Mar 21, 2025Open on DART
- Audit report submitted감사보고서제출Mar 21, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Mar 14, 2025Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 14, 2025Open on DART
- Investment Caution Notice투자유의안내Feb 28, 2025Open on DART
- Other Market Notice기타시장안내Feb 28, 2025Open on DART
- Occurrence of Facts Such as Capital Impairment of 50% or More or Revenue Below ₩5B자본잠식50%이상또는매출액50억원미만사실발생Feb 28, 2025Open on DART
- Occurrence of Facts Such as Capital Impairment of 50% or More or Revenue Below ₩5B자본잠식50%이상또는매출액50억원미만사실발생Feb 28, 2025Open on DART
- Market Notice (Decision on Items for Deliberation by the Corporate Review Committee)기타시장안내 (기업심사위원회 심의대상 결정)Feb 27, 2025Open on DART
- Market Notice (Notice of Additional Grounds for Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 사유 추가 발생 안내)Feb 13, 2025Open on DART
- Occurrence of Embezzlement/Breach of Trust Suspicion횡령ㆍ배임혐의발생Feb 13, 2025Open on DART
- Other Market Notice (Occurrence of Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 사유 발생)Feb 6, 2025Open on DART
- Occurrence of Embezzlement/Breach of Trust Suspicion횡령ㆍ배임혐의발생Feb 6, 2025Open on DART
- [Amended] Confirmation of Embezzlement/Breach of Trust[기재정정]횡령ㆍ배임사실확인Feb 6, 2025Open on DART
- Lawsuit filed or ruled소송등의판결ㆍ결정Jan 6, 2025Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Dec 31, 2024Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Dec 27, 2024Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Dec 27, 2024Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Dec 27, 2024Open on DART
- Confirmation of Embezzlement/Breach of Trust횡령ㆍ배임사실확인Dec 19, 2024Open on DART
- Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 14, 2024Open on DART
- Occurrence of Adverse Opinion, Disclaimer of Opinion, or Complete Capital Impairment in Semi-Annual Review Report반기검토의견부적정,의견거절또는완전자본잠식사실발생Aug 14, 2024Open on DART
- Half-year report (Jun 2024)반기보고서 (2024.06)Aug 14, 2024Open on DART
- Other Informational Disclosure (Informational Disclosure)기타안내사항(안내공시)Jun 25, 2024Open on DART
- Occurrence of Embezzlement/Breach of Trust Suspicion횡령ㆍ배임혐의발생Jun 24, 2024Open on DART
Titles in Korean until English translations are added.
Also known as: 웰바이오텍 / 010600 / KRX:010600
Source: KRX statistical information